Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37


Nicotine Replacement Therapy: An Overview.

Wadgave U, Nagesh L.

Int J Health Sci (Qassim). 2016 Jul;10(3):425-35. Review.


New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products.

Kostygina G, England L, Ling P.

Am J Public Health. 2016 Jul;106(7):1219-22. doi: 10.2105/AJPH.2016.303057. Epub 2016 Apr 14.


Nicotine in high concentration causes contraction of isolated strips of rabbit corpus cavernosum.

Nguyen HB, Lee SY, Park SH, Han JH, Lee MY, Myung SC.

Korean J Physiol Pharmacol. 2015 May;19(3):257-62. doi: 10.4196/kjpp.2015.19.3.257. Epub 2015 Apr 30.


Trajectories of Marijuana Use Beginning in Adolescence Predict Tobacco Dependence in Adulthood.

Brook JS, Lee JY, Brook DW.

Subst Abus. 2015;36(4):470-7. doi: 10.1080/08897077.2014.964901. Epub 2014 Sep 26.


Varenicline for smoking cessation: A review of the literature.

Kaur K, Kaushal S, Chopra SC.

Curr Ther Res Clin Exp. 2009 Feb;70(1):35-54. doi: 10.1016/j.curtheres.2009.02.004. Erratum in: Curr Ther Res Clin Exp. 2010;71(1):89.


Pharmacological intervention of nicotine dependence.

Jain R, Majumder P, Gupta T.

Biomed Res Int. 2013;2013:278392. doi: 10.1155/2013/278392. Epub 2013 Dec 29. Review.


Current and emerging pharmacotherapeutic options for smoking cessation.

Carson KV, Brinn MP, Robertson TA, To-A-Nan R, Esterman AJ, Peters M, Smith BJ.

Subst Abuse. 2013 May 23;7:85-105. doi: 10.4137/SART.S8108. Print 2013.


Medications for substance use disorders.

Douaihy AB, Kelly TM, Sullivan C.

Soc Work Public Health. 2013;28(3-4):264-78. doi: 10.1080/19371918.2013.759031. Review.


Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Carpenter MJ, Jardin BF, Burris JL, Mathew AR, Schnoll RA, Rigotti NA, Cummings KM.

Drugs. 2013 Apr;73(5):407-26. doi: 10.1007/s40265-013-0038-y. Review.


Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration.

Mello NK, Fivel PA, Kohut SJ.

Neuropsychopharmacology. 2013 Jun;38(7):1264-75. doi: 10.1038/npp.2013.25. Epub 2013 Jan 21.


Therapeutic advances in the treatment of nicotine addiction: present and future.

Casella G, Caponnetto P, Polosa R.

Ther Adv Chronic Dis. 2010 May;1(3):95-106. doi: 10.1177/2040622310374896.


Effects of chronic buspirone treatment on cocaine self-administration.

Mello NK, Fivel PA, Kohut SJ, Bergman J.

Neuropsychopharmacology. 2013 Feb;38(3):455-67. doi: 10.1038/npp.2012.202. Epub 2012 Oct 17.


Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry.

Scheidweiler KB, Shakleya DM, Huestis MA.

Clin Chim Acta. 2012 Jun 14;413(11-12):978-84. doi: 10.1016/j.cca.2012.02.017. Epub 2012 Feb 27.


Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.

Walsh SL, Heilig M, Nuzzo PA, Henderson P, Lofwall MR.

Addict Biol. 2013 Mar;18(2):332-43. doi: 10.1111/j.1369-1600.2011.00419.x. Epub 2012 Jan 19.


Targeting nicotine addiction: the possibility of a therapeutic vaccine.

Escobar-Chávez JJ, Domínguez-Delgado CL, Rodríguez-Cruz IM.

Drug Des Devel Ther. 2011;5:211-24. doi: 10.2147/DDDT.S10033. Epub 2011 Apr 18. Review. Erratum in: Drug Des Devel Ther. 2011;5:487.


Correlates of continued tobacco use and intention to quit smoking among Russian cancer patients.

Schnoll RA, Subramanian S, Martinez E, Engstrom PF.

Int J Behav Med. 2011 Dec;18(4):325-32. doi: 10.1007/s12529-010-9131-8.


Anti-cocaine vaccine development.

Kinsey BM, Kosten TR, Orson FM.

Expert Rev Vaccines. 2010 Sep;9(9):1109-14. doi: 10.1586/erv.10.102. Review.


Smoking cessation: an integral part of lung cancer treatment.

Cataldo JK, Dubey S, Prochaska JJ.

Oncology. 2010;78(5-6):289-301. doi: 10.1159/000319937. Epub 2010 Aug 11. Review.


Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists.

Carroll FI, Ma W, Deng L, Navarro HA, Damaj MI, Martin BR.

J Nat Prod. 2010 Mar 26;73(3):306-12. doi: 10.1021/np9006124.


Hormones, nicotine, and cocaine: clinical studies.

Mello NK.

Horm Behav. 2010 Jun;58(1):57-71. doi: 10.1016/j.yhbeh.2009.10.003. Epub 2009 Oct 14. Review.

Supplemental Content

Support Center